Article Versions Notes

Esposito A, Stucchi E, Baronchelli M, Di Mauro P, Ferrari M, Lorini L, Gurizzan C, London NRJ, Hermsen M, Lechner M, et al. Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers. Journal of Clinical Medicine. 2022; 11(22):6787. https://doi.org/10.3390/jcm11226787

Esposito, Andrea, Erika Stucchi, Maria Baronchelli, Pierluigi Di Mauro, Marco Ferrari, Luigi Lorini, Cristina Gurizzan, Nyall Robert Jr London, Mario Hermsen, Matt Lechner, and et al. 2022. "Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers" Journal of Clinical Medicine 11, no. 22: 6787. https://doi.org/10.3390/jcm11226787

Esposito, A., Stucchi, E., Baronchelli, M., Di Mauro, P., Ferrari, M., Lorini, L., Gurizzan, C., London, N. R. J., Hermsen, M., Lechner, M., & Bossi, P. (2022). Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers. Journal of Clinical Medicine, 11(22), 6787. https://doi.org/10.3390/jcm11226787